| pubmed-article:10850191 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10850191 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:10850191 | lifeskim:mentions | umls-concept:C0017601 | lld:lifeskim |
| pubmed-article:10850191 | lifeskim:mentions | umls-concept:C1704292 | lld:lifeskim |
| pubmed-article:10850191 | lifeskim:mentions | umls-concept:C0036454 | lld:lifeskim |
| pubmed-article:10850191 | lifeskim:mentions | umls-concept:C0750572 | lld:lifeskim |
| pubmed-article:10850191 | lifeskim:mentions | umls-concept:C2360800 | lld:lifeskim |
| pubmed-article:10850191 | lifeskim:mentions | umls-concept:C0011318 | lld:lifeskim |
| pubmed-article:10850191 | lifeskim:mentions | umls-concept:C0332293 | lld:lifeskim |
| pubmed-article:10850191 | lifeskim:mentions | umls-concept:C0439792 | lld:lifeskim |
| pubmed-article:10850191 | pubmed:issue | 21 | lld:pubmed |
| pubmed-article:10850191 | pubmed:dateCreated | 2000-6-23 | lld:pubmed |
| pubmed-article:10850191 | pubmed:abstractText | A test survey based on a questionnaire was carried out among Danish eye practitioners. The response rate was 72%. The purpose was to estimate the minimum number of patients suffering from glaucoma (prevalence). Survey results show a prevalence of 0.65%. Further, the survey shows a clear correlation between glaucoma diagnosis and age. The number of glaucoma patients increase from approximately 0.5% for persons 50 years of age to approximately 5% for persons 80 years of age. Seventy-two percent of the diagnosed glaucoma patients have visual field defects at different stages. Six percent have central islands on both eyes, the equivalent of a prevalence for social blindness of 0.04%. Ninety-three percent of the diagnosed glaucoma patients receive anti-glaucomatous treatment, of these 42% combination therapy. Eighty percent of glaucoma patients in combination therapy received three or more drugs. | lld:pubmed |
| pubmed-article:10850191 | pubmed:language | dan | lld:pubmed |
| pubmed-article:10850191 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10850191 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:10850191 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10850191 | pubmed:month | May | lld:pubmed |
| pubmed-article:10850191 | pubmed:issn | 0041-5782 | lld:pubmed |
| pubmed-article:10850191 | pubmed:author | pubmed-author:Damgaard-Jens... | lld:pubmed |
| pubmed-article:10850191 | pubmed:author | pubmed-author:ThygesenJJ | lld:pubmed |
| pubmed-article:10850191 | pubmed:author | pubmed-author:SerurJJ | lld:pubmed |
| pubmed-article:10850191 | pubmed:author | pubmed-author:KessingS VSV | lld:pubmed |
| pubmed-article:10850191 | pubmed:author | pubmed-author:LundbergL ULU | lld:pubmed |
| pubmed-article:10850191 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10850191 | pubmed:day | 22 | lld:pubmed |
| pubmed-article:10850191 | pubmed:volume | 162 | lld:pubmed |
| pubmed-article:10850191 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10850191 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10850191 | pubmed:pagination | 3028-33 | lld:pubmed |
| pubmed-article:10850191 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:10850191 | pubmed:meshHeading | pubmed-meshheading:10850191... | lld:pubmed |
| pubmed-article:10850191 | pubmed:meshHeading | pubmed-meshheading:10850191... | lld:pubmed |
| pubmed-article:10850191 | pubmed:meshHeading | pubmed-meshheading:10850191... | lld:pubmed |
| pubmed-article:10850191 | pubmed:meshHeading | pubmed-meshheading:10850191... | lld:pubmed |
| pubmed-article:10850191 | pubmed:meshHeading | pubmed-meshheading:10850191... | lld:pubmed |
| pubmed-article:10850191 | pubmed:meshHeading | pubmed-meshheading:10850191... | lld:pubmed |
| pubmed-article:10850191 | pubmed:meshHeading | pubmed-meshheading:10850191... | lld:pubmed |
| pubmed-article:10850191 | pubmed:meshHeading | pubmed-meshheading:10850191... | lld:pubmed |
| pubmed-article:10850191 | pubmed:meshHeading | pubmed-meshheading:10850191... | lld:pubmed |
| pubmed-article:10850191 | pubmed:meshHeading | pubmed-meshheading:10850191... | lld:pubmed |
| pubmed-article:10850191 | pubmed:meshHeading | pubmed-meshheading:10850191... | lld:pubmed |
| pubmed-article:10850191 | pubmed:meshHeading | pubmed-meshheading:10850191... | lld:pubmed |
| pubmed-article:10850191 | pubmed:meshHeading | pubmed-meshheading:10850191... | lld:pubmed |
| pubmed-article:10850191 | pubmed:year | 2000 | lld:pubmed |
| pubmed-article:10850191 | pubmed:articleTitle | [Glaucoma patients treated by practicing ophthalmologists in Denmark. Estimated number of patients and the extent of visual field defects]. | lld:pubmed |
| pubmed-article:10850191 | pubmed:affiliation | Danske Ojenlaegers Organisation, København. | lld:pubmed |
| pubmed-article:10850191 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:10850191 | pubmed:publicationType | English Abstract | lld:pubmed |
| pubmed-article:10850191 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10850191 | lld:pubmed |
